Metastatic Colon Cancer Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03043313Tucatinib (ONT-380) and Trastuzumab in Treating Patients With HER2+ Metastatic Colorectal CancerTreatment